ABC News is reporting that thousands of men in Pennsylvania, and possibly the world over, may have received erroneous PSA test results showing higher than actual levels–and possibly leading to unnecessary biopsies. PSA, or prostate specific antigen levels, are a benchmark physicians use to gauge the likelihood of prostate cancer in their patients. According to the report, the makers of the test issued a global recall in June, citing a 20-23% “positive bias”. The specific product recalled is the Immulite PSA test.
Read more posts on prostate cancer news:
Preventing Climacturia (Urine leakage during sex)